Impressively, assessment of the cytotoxicity of CBPD-409 in a large panel of 136 cell lines from 20 distinct lineages found AR-positive prostate cancer cells to be among the most sensitive models (Fig. 5d). This evidence concerns the gene AR and prostate carcinoma.